Drug Abuse Testing Market Scope
Drug abuse is the deliberate consumption of an illegal drug or overindulgence of a prescribed psychoactive or performance-enhancing drug for non-therapeutic, non-medicinal use/effects. Addicted individuals have uncontrollable, irresistible, and compulsive desire and persistence in its use despite negative consequences. Drug abuse test is a non-invasive technical analysis of biological samples. There are a number of ways this can be done, including pre-employment testing, random testing, reasonable suspicion/cause testing, post-accident testing, return to duty testing and follow-up testing. This usually involves collecting urine samples to test for drugs such as marijuana, cocaine, amphetamines, PCP, and opiates.
The Drug Abuse Testing market study is segmented by Type (Analyzers, Rapid Testing Devices, Consumables and Laboratory Services) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Quest Diagnostics (United States), Laboratory Corporation of America Holdings (LabCorp) (United States), Abbott Laboratories (United States), Randox laboratories (United Kingdom), Bio-Rad Laboratories, Inc.(United States), Sonic Healthcare (Australia), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific, Inc. (United States), Shimadzu Corporation, Danaher Corporation, Siemens AG, Merck KGaA, Drägerwerk AG & Co. KGaA, bioMérieux SA and Waters Corporation are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Drug Abuse Testing market by Type, Application and Region.
On the basis of geography, the market of Drug Abuse Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In Feb. 2019, Quest Diagnostics and Houston Healthcare are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement under which Quest will provide full laboratory management services for Houston Medical Center and Perry Hospital.
In Jul 2019, Shimadzu Corporation has released version 2 of its GC/MS Forensic Toxicological Database for gas chromatograph mass spectrometers (GC/MS). Since 2010, Shimadzu has been marketing a database for the simultaneous screening of forensic chemicals such as drugs and/or toxic substances to police crime laboratories, university forensic departments, and emersency care facilities
Market Trend
- Development of Novel Drug Testing Equipment
Market Drivers
- Increasing Number of People who Consume Alcohol and Illicit Drugs such as Marijuana, Cocaine, and Others
- Growing Drug related Mortality
Opportunities
- Stringent Government Regulations Mandating Drug Screening
- Technological Advancements in Drug Screening/Testing Devices
Restraints
- Consideration of Drug Testing as a Breach of Privacy Rights in Certain Countries
Challenges
- Lack of Awareness related Drug Abuse Testing
Key Target Audience
Drug Abuse Testing Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase